SHARE: +/-: -0.08 SEK / Bid: 7.64 SEK / Ask: 7.78 SEK / Price: 7.82 SEK / High: 7.94 SEK / Low: 7.62 SEK / Quantity: 37 056 / Turnover: 285 084 SEK / 2021-01-27 16:26 (CET)
 

Business Development

Spago Nanomedical focuses on the development of novel nanomedical tumor selective products for cancer diagnostics and therapy.

We welcome a dialogue with potential partners regarding cooperation and out-licensing of the company’s projects and technologies.

For more information regarding business development, please contact CEO Mats Hansen at mats.hansen@spagonanomedical.se